Nordic Life Science Days and ECCP2014 merge

Oslo Cancer Cluster and French partner Cancer-Bio-Santé are joining forces with SwedenBio to offer the global Life Science industry the largest partnering conference in the Nordics – Nordic Life Science Days featuring the 6th European Cancer Cluster Partnering. Already now oncology biotechs, early stage companies and academics may submit an application for presenting at NLSDays-ECCP […]

5 Oslo Cancer Cluster SMEs granted BIA-funding

The Norwegian Research Council recently granted BerGenBio, PCI Biotech, Lytix Biopharma, Oncoinvent and Ultimovacs –  all Oslo Cancer Cluster member companies – funding  through the Programme for User-Driven Research Based Innovation (BIA). In total, the Research Council will grant a record amount of 444 million to 58 Norwegian companies over four years, of which 10 are […]

Presentations from cancer nanomedicine seminar

Friday January 31 Oslo Cancer Cluster, SINTEF, NTNU, Oslo University Hospital and the Norwegian Cancer Society  invite Norwegian media and other interested parties to join a breakfast seminar on nano cancer medicine. The seminar is held in conjunction with 12 similair events across the whole of Europe in relation to Nano World Cancer Day. Below […]

Trying out life as oncology researchers

Six biology students from Ullern High School were selected to intern at the Department of Tumor Biology at Oslo University Hospital in week 50. This is the fourth time the department has had students from Ullern interning, says researcher Birgit Engesæter. Together with her research colleague Siri Tveito, she is in charge of the students […]

Norwegian Cancer Society initiate investment fund

The newly employed Head of Biotech Investments in The Norwegian Cancer Society, Sigrid Fossheim, has already had several meetings with potential oncology companies to invest in. – We aim to make our first investment before the Summer of 2014, says Fossheim. The Norwegian Cancer Society is the largest private contributor to cancer research in Norway. […]